Immune suppression by cancer is related to a decrease in TCR diversity and a decrease in activated CD4+ CD8+ lymphocytes, whereas a patient’s immune capacity refers to a physical ability to sufficiently replenish these lymphocytes when they are exhausted [4]. Here, CD8A is linked to cancer.